• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[新型大环内酯类药物]

[New macrolides].

作者信息

Portier H, Buisson M, Chavanet P

机构信息

Service des maladies infectieuses et tropicales, CHU du Bocage, Dijon.

出版信息

Rev Prat. 1994 Jun 15;44(12):1629-34.

PMID:7939238
Abstract

The macrolides are still widely used in general practice and the new 14- or 15 membered-ring compounds-roxithromycin, clarithromycin, dirithromycin, azithromycin -may offer a new development. Their antibacterial activity is similar to erythromycin but azithromycin is more active against Gram negative strams. Roxythromycin exhibits high serum concentrations; azithromycin and dirithromycin present low serum concentrations but prolonged half-lives allowing a reduction of the duration of treatment particularly for pharyngitis (azithromycin). Macrolides are less useful for otitis and sinusitis treatment since their activity against H. influenzae and S. pneumoniae are weak. The activity against atypical bacteria justify their choice as first line treatment for benign atypical pneumonia of healthy young adults and for sexually transmitted diseases. In AIDS, these compounds are indicated in mycobacteriosis (clarithromycin), bacillary angiomatosis and excavated pneumonia due to Rhodococcus equi. Clinical tolerance is very good, particularly the gastro-intestinal one. The reported drug interactions are those of this class of antibiotics.

摘要

大环内酯类药物仍广泛应用于普通医疗实践中,新型的14或15元环化合物——罗红霉素、克拉霉素、地红霉素、阿奇霉素——可能代表了一个新的发展方向。它们的抗菌活性与红霉素相似,但阿奇霉素对革兰氏阴性菌更具活性。罗红霉素血清浓度较高;阿奇霉素和地红霉素血清浓度较低,但半衰期延长,尤其对于咽炎(阿奇霉素)而言,可缩短治疗疗程。大环内酯类药物对中耳炎和鼻窦炎的治疗效果欠佳,因为它们对流感嗜血杆菌和肺炎链球菌的活性较弱。其对非典型细菌的活性使其成为健康年轻成人良性非典型肺炎和性传播疾病一线治疗药物的选择。在艾滋病患者中,这些化合物可用于治疗分枝杆菌病(克拉霉素)、杆菌性血管瘤病以及由马红球菌引起的空洞性肺炎。临床耐受性非常好,尤其是胃肠道耐受性。所报道的药物相互作用是这类抗生素常见的。

相似文献

1
[New macrolides].[新型大环内酯类药物]
Rev Prat. 1994 Jun 15;44(12):1629-34.
2
Comparative in vitro evaluation of dirithromycin tested against recent clinical isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae, including effects of medium supplements and test conditions on MIC results.针对流感嗜血杆菌、卡他莫拉菌和肺炎链球菌近期临床分离株对地红霉素进行的体外比较评估,包括培养基补充成分和试验条件对最低抑菌浓度(MIC)结果的影响。
Diagn Microbiol Infect Dis. 1999 Apr;33(4):275-82.
3
Review of macrolides and ketolides: focus on respiratory tract infections.大环内酯类和酮内酯类药物综述:聚焦呼吸道感染
Drugs. 2001;61(4):443-98. doi: 10.2165/00003495-200161040-00003.
4
Comparative in vitro potencies of nine new macrolides.九种新型大环内酯类药物的体外效价比较
Drugs Exp Clin Res. 1988;14(7):445-51.
5
The new macrolides: expanding the ways in antibiotic treatment.新型大环内酯类药物:拓展抗生素治疗途径
Bol Asoc Med P R. 1992 Jan;84(1):21-5.
6
The macrolides: erythromycin, clarithromycin, and azithromycin.大环内酯类药物:红霉素、克拉霉素和阿奇霉素。
Mayo Clin Proc. 1999 Jun;74(6):613-34. doi: 10.4065/74.6.613.
7
Macrolide antibiotics.大环内酯类抗生素
Dent Today. 1997 Nov;16(11):72, 74-5, 78-9.
8
[Comparative in vitro activity of new oral macrolides against Streptococcus pyogenes strains].新型口服大环内酯类药物对化脓性链球菌菌株的体外活性比较
Rev Med Chil. 1993 Oct;121(10):1128-34.
9
[Macrolides. New therapeutic prospects].
Presse Med. 1994 Dec 3;23(38):1762-6.
10
Empirical therapy of community-acquired pneumonia: macrolides are not ideal choices.社区获得性肺炎的经验性治疗:大环内酯类药物并非理想选择。
Semin Respir Infect. 1997 Dec;12(4):329-33.